They also suggested that the change of peripheral KP metabolites is supposed to be interpreted cautiously because central KP metabolites have different abilities to cross BBB, and this raises the question of whether blood is an appropriate medium to reflect the alterations of those complex components in KP related to neuropathology in HD or other NDs [235]. This evidence concerns the gene NPPA and Huntington disease.